 The name of the company, by the way, NRX Pharmaceuticals, they're publicly traded. NRXP is a stock symbol, NRXP. We've got Dr. Jonathan Javid here. So talk about the intersection of NRXP and this question, if ketamine is headed to be the standard of care. Have you talked about the FDA? As far as we know, we're the first people who are heading to the FDA with an intravenous form of ketamine that should be approvable.